MedPath

Feeding Tolerance Evaluation

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: infant formula
Registration Number
NCT02405572
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

Crossover study of 2 infant formulas

Detailed Description

Exclusively formula-fed infants will participate in two 2-week feeding periods of 2 infant formulas. Daily tolerance records will be kept by caregivers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  • Healthy newborn infant
  • Full-term (> 37 weeks gestation)
  • 0-2 months (birth-56 days) of age on enrollment
  • Infant exclusively formula-fed for at least 2 days prior to enrollment
  • Having obtained his/her legal representative's informed consent
Exclusion Criteria
  • Known or suspected cow-milk allergy
  • Congenital illness or malformation
  • Significant prenatal and/or postnatal disease
  • Currently participating in another clinical study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Formula 2infant formulainfant formula
Formula 1infant formulainfant formula
Primary Outcome Measures
NameTimeMethod
stool consistency2 weeks

caregivers will document on diary records

Secondary Outcome Measures
NameTimeMethod
stool pattern2 weeks

caregivers will document on diary records

sleep pattern2 weeks

caregivers will document on diary records

adverse events2 weeks

assessed throughout the study

mood2 weeks

caregivers will document on diary records

formula intake2 weeks

caregivers will document on diary records

spit-up pattern2 weeks

caregivers will document on diary records

Trial Locations

Locations (2)

Pedia Research

🇺🇸

Owensboro, Kentucky, United States

Tanner Clinic

🇺🇸

Layton, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath